Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nebulizers and Vaporizers | 2 | 2020 | 139 | 0.810 |
Why?
|
Choriocarcinoma | 1 | 2021 | 126 | 0.780 |
Why?
|
Lithiasis | 1 | 2019 | 20 | 0.700 |
Why?
|
Pleural Effusion | 1 | 2021 | 337 | 0.640 |
Why?
|
Bronchial Diseases | 1 | 2019 | 151 | 0.630 |
Why?
|
Monitoring, Ambulatory | 1 | 2019 | 358 | 0.530 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2014 | 15 | 0.510 |
Why?
|
Pulmonary Emphysema | 1 | 2020 | 672 | 0.490 |
Why?
|
Aspergillus fumigatus | 1 | 2014 | 150 | 0.460 |
Why?
|
Orthomyxoviridae | 1 | 2014 | 156 | 0.450 |
Why?
|
Pneumonectomy | 1 | 2020 | 1098 | 0.450 |
Why?
|
Uterine Neoplasms | 1 | 2021 | 1513 | 0.420 |
Why?
|
Disease Management | 1 | 2019 | 2459 | 0.320 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3047 | 0.310 |
Why?
|
Gram-Positive Bacterial Infections | 3 | 2014 | 340 | 0.280 |
Why?
|
Vancomycin Resistance | 3 | 2014 | 128 | 0.250 |
Why?
|
Influenza, Human | 1 | 2014 | 1480 | 0.230 |
Why?
|
Enterococcus faecalis | 2 | 2013 | 247 | 0.200 |
Why?
|
Exudates and Transudates | 1 | 2021 | 172 | 0.190 |
Why?
|
Cough | 2 | 2021 | 555 | 0.190 |
Why?
|
Hemoptysis | 1 | 2021 | 155 | 0.180 |
Why?
|
Pulmonary Sclerosing Hemangioma | 1 | 2019 | 4 | 0.170 |
Why?
|
Lung Neoplasms | 1 | 2021 | 13112 | 0.150 |
Why?
|
Bronchodilator Agents | 1 | 2020 | 502 | 0.140 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 1740 | 0.120 |
Why?
|
Comorbidity | 3 | 2019 | 10380 | 0.120 |
Why?
|
Health Services | 1 | 2019 | 758 | 0.120 |
Why?
|
Dyspnea | 1 | 2021 | 1303 | 0.120 |
Why?
|
Bronchoscopy | 1 | 2019 | 861 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 912 | 0.110 |
Why?
|
Community-Acquired Infections | 2 | 2013 | 465 | 0.110 |
Why?
|
Immunocompromised Host | 2 | 2014 | 847 | 0.100 |
Why?
|
Cephalosporins | 1 | 2012 | 203 | 0.100 |
Why?
|
beta-Lactamases | 1 | 2013 | 304 | 0.100 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2018 | 1381 | 0.090 |
Why?
|
Fluoroquinolones | 1 | 2012 | 308 | 0.090 |
Why?
|
Antifungal Agents | 1 | 2014 | 729 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2014 | 1851 | 0.090 |
Why?
|
Leukemia | 1 | 2018 | 1509 | 0.090 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 532 | 0.080 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 689 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12954 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2683 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2063 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4210 | 0.080 |
Why?
|
Bacteremia | 1 | 2014 | 963 | 0.070 |
Why?
|
Escherichia coli Proteins | 1 | 2013 | 1050 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1832 | 0.070 |
Why?
|
Lung Transplantation | 1 | 2014 | 1155 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3020 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 7172 | 0.060 |
Why?
|
Female | 11 | 2021 | 380020 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2018 | 3679 | 0.060 |
Why?
|
Humans | 14 | 2021 | 743811 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2018 | 5316 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2593 | 0.060 |
Why?
|
Lung Diseases | 1 | 2014 | 1887 | 0.060 |
Why?
|
Microbial Sensitivity Tests | 3 | 2014 | 1870 | 0.060 |
Why?
|
Disease Progression | 1 | 2019 | 13273 | 0.050 |
Why?
|
Antiviral Agents | 1 | 2014 | 2984 | 0.050 |
Why?
|
Michigan | 2 | 2013 | 350 | 0.050 |
Why?
|
Odds Ratio | 1 | 2014 | 9848 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 2958 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2020 | 63042 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12243 | 0.050 |
Why?
|
Escherichia coli | 1 | 2013 | 4216 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2018 | 5445 | 0.050 |
Why?
|
Middle Aged | 8 | 2019 | 213241 | 0.040 |
Why?
|
Pregnancy | 1 | 2021 | 29140 | 0.040 |
Why?
|
Drug Resistance, Multiple, Bacterial | 2 | 2013 | 564 | 0.040 |
Why?
|
Electronics | 1 | 2020 | 321 | 0.040 |
Why?
|
Risk Factors | 5 | 2018 | 72252 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2020 | 1105 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20121 | 0.030 |
Why?
|
Aged | 6 | 2019 | 163178 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 56392 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 840 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2019 | 77410 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2012 | 5752 | 0.030 |
Why?
|
Daptomycin | 1 | 2014 | 73 | 0.030 |
Why?
|
beta-Lactams | 1 | 2014 | 159 | 0.030 |
Why?
|
Male | 7 | 2019 | 349776 | 0.030 |
Why?
|
Equipment Design | 1 | 2020 | 3574 | 0.020 |
Why?
|
Ciprofloxacin | 1 | 2013 | 314 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 21733 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 427 | 0.020 |
Why?
|
Genes, Bacterial | 1 | 2013 | 1078 | 0.020 |
Why?
|
Aged, 80 and over | 4 | 2014 | 57744 | 0.020 |
Why?
|
Hospital Costs | 1 | 2014 | 985 | 0.020 |
Why?
|
Acute Disease | 1 | 2018 | 7150 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2013 | 788 | 0.020 |
Why?
|
Adult | 4 | 2019 | 213889 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2013 | 2707 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15067 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 40545 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15526 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18355 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 29052 | 0.010 |
Why?
|
United States | 1 | 2013 | 69859 | 0.000 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_